Compare WFCF & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WFCF | CVM |
|---|---|---|
| Founded | 1996 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.5M | 53.1M |
| IPO Year | 2011 | 1987 |
| Metric | WFCF | CVM |
|---|---|---|
| Price | $11.10 | $4.81 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.4K | ★ 73.7K |
| Earning Date | 11-13-2025 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.82 | N/A |
| EPS | ★ 0.53 | N/A |
| Revenue | ★ $25,512,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $20.83 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.26 | $1.98 |
| 52 Week High | $13.78 | $21.93 |
| Indicator | WFCF | CVM |
|---|---|---|
| Relative Strength Index (RSI) | 33.52 | 32.74 |
| Support Level | $10.75 | $4.01 |
| Resistance Level | $12.13 | $6.75 |
| Average True Range (ATR) | 0.55 | 0.48 |
| MACD | -0.19 | -0.11 |
| Stochastic Oscillator | 11.57 | 29.19 |
Where Food Comes From Inc is a third-party food verification company. It offers food production audits and uses verification processes to ensure that claims made by food producers and processors are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. The company operates in two segments that are verification and certification and Software Sales and Related Consulting. It generates the majority of its revenue from verification and certification.
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.